Abstract
Immunoglobulin (Ig)G4-related disease (IgG4-RD) with retroperitoneal fibrosis (RPF) is a rare, fibroinflammatory disease involving the soft tissues of the retroperitoneum. A 73-year-old man with IgG4-related RPF affecting the abdominal aorta and iliac arteries was treated with steroids and mycophenolate mofetil. The prevalence of the disease remains unknown because it is often misdiagnosed and can mimic many malignant, infectious, and inflammatory conditions. Autoimmune pancreatitis is a common presenting condition of IgG4-RD. Because As IgG4-RD is responsive to steroids, diagnosing IgG4-related RPF early can prevent the exposure of patients with RPF to unnecessary diagnostic and therapeutic interventions.
Highlights
CASE REPORTA 73-year-old white man had presented to the emergency department with a 3-week history of left flank pain radiating to the groin and associated with dark urine
Immunoglobulin (Ig)G4-related disease (IgG4-RD) with retroperitoneal fibrosis (RPF) is a rare, fibroinflammatory disease involving the soft tissues of the retroperitoneum
Retroperitoneal fibrosis (RPF) is a rare heterogeneous disease of unknown etiology characterized by inflammation and fibrosis of the retroperitoneum that often presents a diagnostic challenge
Summary
A 73-year-old white man had presented to the emergency department with a 3-week history of left flank pain radiating to the groin and associated with dark urine His background included hypercholesterolemia, chronic obstructive pulmonary disease, and an episode of pancreatitis 20 months previously that had been suspected to be related to statin use (Fig 1). A computed tomography (CT) angiogram showed extensive para-aortic soft tissue changes around the abdominal aorta and common iliac arteries causing left ureteral obstruction and moderate hydronephrosis of the left kidney (Fig 2). At this stage, an inflammatory abdominal aortic aneurysm was strongly suspected, with a differential diagnosis of aortitis vs RPF. He remained asymptomatic, with no signs of relapse at 15 months of follow-up
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Journal of vascular surgery cases and innovative techniques
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.